These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 18690105)

  • 21. Mechanisms of disease: neurogenetics of MeCP2 deficiency.
    Francke U
    Nat Clin Pract Neurol; 2006 Apr; 2(4):212-21. PubMed ID: 16932552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rett syndrome: from the gene to the disease.
    Matijevic T; Knezevic J; Slavica M; Pavelic J
    Eur Neurol; 2009; 61(1):3-10. PubMed ID: 18948693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive and social functions and growth factors in a mouse model of Rett syndrome.
    Schaevitz LR; Moriuchi JM; Nag N; Mellot TJ; Berger-Sweeney J
    Physiol Behav; 2010 Jun; 100(3):255-63. PubMed ID: 20045424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of brain morphology in Mecp2 mutant mouse models of Rett syndrome.
    Belichenko NP; Belichenko PV; Li HH; Mobley WC; Francke U
    J Comp Neurol; 2008 May; 508(1):184-95. PubMed ID: 18306326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The p.Val66Met polymorphism in the BDNF gene protects against early seizures in Rett syndrome.
    Nectoux J; Bahi-Buisson N; Guellec I; Coste J; De Roux N; Rosas H; Tardieu M; Chelly J; Bienvenu T
    Neurology; 2008 May; 70(22 Pt 2):2145-51. PubMed ID: 18434641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biogenic amines in Rett syndrome: the usual suspects.
    Roux JC; Villard L
    Behav Genet; 2010 Jan; 40(1):59-75. PubMed ID: 19851857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rett syndrome treatment in mouse models: searching for effective targets and strategies.
    Ricceri L; De Filippis B; Laviola G
    Neuropharmacology; 2013 May; 68():106-15. PubMed ID: 22940001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome.
    Medrihan L; Tantalaki E; Aramuni G; Sargsyan V; Dudanova I; Missler M; Zhang W
    J Neurophysiol; 2008 Jan; 99(1):112-21. PubMed ID: 18032561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome--Mecp2 gene dosage effects and BDNF expression.
    Kondo M; Gray LJ; Pelka GJ; Christodoulou J; Tam PP; Hannan AJ
    Eur J Neurosci; 2008 Jun; 27(12):3342-50. PubMed ID: 18557922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome.
    Buoni S; Zannolli R; Felice CD; Saponari S; Strambi M; Dotti MT; Castrucci E; Corbini L; Orsi A; Hayek J
    Clin Neurophysiol; 2008 Nov; 119(11):2455-8. PubMed ID: 18842453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synaptic plasticity deficits in an experimental model of rett syndrome: long-term potentiation saturation and its pharmacological reversal.
    Weng SM; McLeod F; Bailey ME; Cobb SR
    Neuroscience; 2011 Apr; 180():314-21. PubMed ID: 21296130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice.
    Jugloff DG; Vandamme K; Logan R; Visanji NP; Brotchie JM; Eubanks JH
    Hum Mol Genet; 2008 May; 17(10):1386-96. PubMed ID: 18223199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal brain MRI study in a mouse model of Rett Syndrome and the effects of choline.
    Ward BC; Agarwal S; Wang K; Berger-Sweeney J; Kolodny NH
    Neurobiol Dis; 2008 Jul; 31(1):110-9. PubMed ID: 18571096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Environmental enrichment alters locomotor behaviour and ventricular volume in Mecp2 1lox mice.
    Nag N; Moriuchi JM; Peitzman CG; Ward BC; Kolodny NH; Berger-Sweeney JE
    Behav Brain Res; 2009 Jan; 196(1):44-8. PubMed ID: 18687363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lithium and antidepressants: potential agents for the treatment of Rett syndrome.
    Tsai SJ
    Med Hypotheses; 2006; 67(3):626-9. PubMed ID: 16584849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An explanation for another familial case of Rett syndrome: maternal germline mosaicism.
    Venâncio M; Santos M; Pereira SA; Maciel P; Saraiva JM
    Eur J Hum Genet; 2007 Aug; 15(8):902-4. PubMed ID: 17440498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ups and downs of BDNF in Rett syndrome.
    Sun YE; Wu H
    Neuron; 2006 Feb; 49(3):321-3. PubMed ID: 16446133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized.
    Bienvenu T; Chelly J
    Nat Rev Genet; 2006 Jun; 7(6):415-26. PubMed ID: 16708070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. X chromosome inactivation in Rett Syndrome and its correlations with MECP2 mutations and phenotype.
    Xinhua Bao ; Shengling Jiang ; Fuying Song ; Hong Pan ; Meirong Li ; Wu XR
    J Child Neurol; 2008 Jan; 23(1):22-5. PubMed ID: 18184939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of postnatal dietary choline supplementation on motor regional brain volume and growth factor expression in a mouse model of Rett syndrome.
    Nag N; Mellott TJ; Berger-Sweeney JE
    Brain Res; 2008 Oct; 1237():101-9. PubMed ID: 18778693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.